NOVO NORDISK: Barclays optimistic on the file








Emily Field of Barclays sees the stock as a buying opportunity. The target price remains fixed at 825 DKK.

Zonebourse with dpa-AFX Analyzer 2022

All the news about NOVO NORDISK A/S

Analyst Recommendations for NOVO NORDISK A/S

Financial data

2022 turnover 171 billion
23,592M
23,170M
2022 net result 54,510M
7,513M
7,379M
trso. net 2022 2,051M
283M
278M
PER 202231.5x
2022 return1.54%
Capitalization 1,745 billion
239 billion
236 billion
VE / CA 202210.2x
VE / CA 20238.89x
Number of employees50,816
Floating69.6%

Chart NOVO NORDISK A/S


Hard :

Period:




Novo Nordisk A/S : Chart technical analysis Novo Nordisk A/S | Market area

Trends technical analysis NOVO NORDISK A/S

Short termMiddle termLong term
Trendsbearishbullishbullish

Evolution of the Income Statement

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts26
Last Closing PriceDKK770.00
Average price targetDKK827.04
Deviation / Average Target7.41%

Officers and Directors




Source link -88